We are live on
!
Find out more
X
Xponance Portfolio holdings
AUM
$16.3B
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter
Est. Return
+26.68%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$3.87B
AUM Growth
+$3.75B
(+3,058%)
Cap. Flow
+$3.47B
Cap. Flow
% of AUM
89.61%
Top 10 Holdings %
Top 10 Hldgs %
31.89%
Holding
1,113
New
1,003
Increased
13
Reduced
12
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$256M |
| 2 |
Apple
AAPL
|
+$238M |
| 3 |
Amazon
AMZN
|
+$190M |
| 4 |
Meta Platforms (Facebook)
META
|
+$97.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$75.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$15.8M |
| 2 |
iShares MSCI India ETF
INDA
|
+$2.7M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$2.36M |
| 4 |
ERUS
iShares MSCI Russia ETF
ERUS
|
+$1.43M |
| 5 |
Canadian National Railway
CNI
|
+$785K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.23% |
| 2 | Healthcare | 14.15% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.06% |
| 5 | Communication Services | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Ares Management
ARES
$32.1B
| $404K | 0.01% |
+10,167
| New | +$359K |
|
702
Bio-Rad Laboratories Class A
BIO
$10.4B
| $403K | 0.01% |
+892
| New | +$394K |
|
703
Darden Restaurants
DRI
$24.5B
| $402K | 0.01% |
+5,299
| New | +$376K |
|
704
Kemper
KMPR
$1.65B
| $402K | 0.01% |
+5,538
| New | +$370K |
|
705
MDU Resources
MDU
$4.16B
| $402K | 0.01% |
+47,711
| New | +$396K |
|
|
LSI
706
DELISTED
Life Storage, Inc.
LSI
| $402K | 0.01% |
+6,347
| New | +$394K |
|
707
Ionis Pharmaceuticals
IONS
$10.1B
| $400K | 0.01% |
+6,786
| New | +$377K |
|
708
Middleby
MIDD
$5.1B
| $399K | 0.01% |
+5,059
| New | +$328K |
|
709
Advance Auto Parts
AAP
$2.59B
| $398K | 0.01% |
+2,795
| New | +$355K |
|
710
Cousins Properties
CUZ
$4.85B
| $398K | 0.01% |
+13,345
| New | +$401K |
|
711
Idacorp
IDA
$7.85B
| $398K | 0.01% |
+4,556
| New | +$411K |
|
|
EV
712
DELISTED
Eaton Vance Corp.
EV
| $398K | 0.01% |
+10,299
| New | +$375K |
|
713
Cincinnati Financial
CINF
$26.4B
| $396K | 0.01% |
+6,181
| New | +$408K |
|
714
Woodward
WWD
$20.2B
| $396K | 0.01% |
+5,112
| New | +$334K |
|
715
Ingersoll Rand
IR
$30.5B
| $395K | 0.01% |
+14,033
| New | +$396K |
|
716
Ziff Davis
ZD
$1.91B
| $395K | 0.01% |
+7,185
| New | +$470K |
|
717
Iovance Biotherapeutics
IOVA
$3.63B
| $393K | 0.01% |
+14,325
| New | +$471K |
|
718
Invesco S&P SmallCap Information Technology ETF
PSCT
$478M
| $393K | 0.01% |
13,560
-14,889
| -52% | -$401K |
|
719
Grand Canyon Education
LOPE
$3.94B
| $391K | 0.01% |
+4,318
| New | +$384K |
|
720
Louisiana-Pacific
LPX
$4.98B
| $391K | 0.01% |
+15,225
| New | +$322K |
|
721
Flowers Foods
FLO
$1.51B
| $390K | 0.01% |
+17,440
| New | +$393K |
|
722
Dentsply Sirona
XRAY
$2.22B
| $390K | 0.01% |
+8,849
| New | +$374K |
|
723
AES
AES
$10.5B
| $389K | 0.01% |
+26,867
| New | +$353K |
|
|
NUVA
724
DELISTED
NuVasive, Inc.
NUVA
| $389K | 0.01% |
+6,983
| New | +$404K |
|
725
Eastman Chemical
EMN
$8.35B
| $388K | 0.01% |
+5,565
| New | +$351K |
|
Similar funds
PCM
LPC
CAM
MFG
PAM
BS
BBVA
NMO
Xponance's Q2 2020 Portfolio in Review
As of Q2 2020, Xponance held 1,113 positions worth $3.87B, up 3,058% from $123M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Xponance deployed $3.47B of net new capital in Q2 2020, opening 1,003 new positions and adding to 13 existing holdings. Its largest new stake was Microsoft: 1,408,872 shares worth $287M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was iShares Core MSCI Emerging Markets ETF, an estimated $2.36M trimmed.
- Xponance's largest Q2 2020 buy was Microsoft: 1,408,872 shares worth $287M.
- Xponance added most to Occidental Petroleum in Q2 2020, an estimated $4.96M increase.
- Xponance's biggest Q2 2020 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $2.36M.
- Xponance fully exited iShares MSCI ACWI ex US ETF in Q2 2020, selling an estimated $15.8M.
- Xponance's ten largest holdings make up 32% of its $3.87B portfolio in Q2 2020.
- Xponance opened 1,003 new positions and closed 82 in Q2 2020.
- Xponance's portfolio value rose 3,058% quarter-over-quarter to $3.87B.
Based on Xponance's 13F filing for Q2 2020, filed 14 Aug 2020.